Hangzhou Tigermed Consulting Co Ltd Sustainability Reports
The company operates as a clinical Contract Research Organization (CRO) that provides comprehensive research and development services for the biopharmaceutical and medical device industries. Its offerings span across preclinical development, clinical trials, and clinical research consulting services.
Sector: Professional & technical services
Country: China
Exchange: Shenzhen Stock Exchange
LEI: 300300CP4N8WDF6DOO67
FIGI: BBG002PKXG10
14 reports from 2018 to 2025